It’s back to school and back to work! Get into the swing of things by catching up on the latest news in the research ethics world (which never goes on vacation)!
Aveo Reeling after FDA's Rejection of Kidney Cancer Drug: Aveo Pharmaceuticals spent seven years and $300 million developing tivozanib, a kidney cancer drug, which was recently rejected by the [...] Read more
by Joan Rachlin, JD, MPH, Executive Director
One of my close friends runs the Civil Rights and Restorative Justice Project at Northeastern University School of Law, a project that seeks to achieve justice for civil rights era crimes that went unpunished. Last year, I attended a [...] Read more
by Maeve Luthin, JD, Professional Development Manager
In June’s Association for Molecular Pathology v. Myriad Genetics, Inc. (Myriad) decision, the Supreme Court determined that human genes fall within the “laws of nature” exception to patentable material. This decision invalidated Myriad’s exclusive claim to BRCA 1 and BRCA 2 tests that can be used in determining a woman’s risk in contracting breast and ovarian cancer. However, Myriad wasn’[...] Read more
by Maeve Luthin, JD, Project Coordinator
It’s your favorite time of the week again! Take a few minutes to catch up with the research ethics world by reading through this edition of our Research Ethics Roundup.
US Regulator Plans to Declare Research Chimps Endangered: The US Fish and Wildlife Service Read more
Spring is in full swing! Take advantage of the mild weather and enjoy the great outdoors while reading the full text of this week’s Research Ethics Roundup selections.
#NIHSequesterImpact: Last week, Francis Collins, director of the National Institutes of Health, [...] Read more